Jun Hou Selected Research

Capecitabine (Xeloda)

6/2018	Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis.
1/2018	Platelet-to-lymphocyte ratio and lymphocyte-to-white blood cell ratio predict the efficacy of neoadjuvant chemotherapy and the prognosis of locally advanced gastric cancer patients treated with the oxaliplatin and capecitabine regimen.
11/2016	Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX).
6/2014	A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Hou Research Topics

Disease

70	Neoplasms (Cancer) 04/2024 - 04/2009
25	Infections 12/2023 - 03/2006
13	Fibrosis (Cirrhosis) 01/2023 - 01/2012
12	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2009
11	Hepatocellular Carcinoma (Hepatoma) 07/2023 - 03/2012
11	Stomach Neoplasms (Stomach Cancer) 01/2020 - 08/2012
8	Adenocarcinoma 10/2022 - 11/2008
8	Carcinoma (Carcinomatosis) 12/2019 - 12/2003
6	Hypoxia (Hypoxemia) 12/2023 - 07/2006
6	Diabetic Cardiomyopathies 11/2023 - 09/2013
6	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 12/2016
6	Hepatitis 01/2017 - 03/2002
5	Liver Neoplasms (Liver Cancer) 05/2023 - 01/2020
5	Carcinogenesis 11/2022 - 01/2014
5	Inflammation (Inflammations) 11/2022 - 03/2016
5	Esophageal Squamous Cell Carcinoma 10/2022 - 08/2012
5	Neuroinflammatory Diseases 01/2022 - 12/2016
5	Hepatitis B 09/2016 - 03/2002
4	Disease Progression 02/2024 - 01/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 04/2023 - 01/2022
4	Brain Injuries (Brain Injury) 01/2022 - 12/2016
4	Wounds and Injuries (Trauma) 01/2022 - 01/2014
4	Renal Cell Carcinoma (Grawitz Tumor) 11/2021 - 02/2009
4	Takayasu Arteritis (Arteritis, Takayasu's) 01/2021 - 04/2012
4	Chronic Hepatitis B 01/2019 - 03/2006
4	Lymphatic Metastasis 01/2016 - 06/2014
3	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 01/2018
3	Hemorrhage 05/2023 - 01/2015
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 06/2015
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 06/2015
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2012
3	Esophageal Neoplasms (Esophageal Cancer) 12/2021 - 06/2002
3	COVID-19 05/2021 - 01/2021
3	Chronic Hepatitis C 01/2016 - 11/2014
3	Cytomegalovirus Infections (Inclusion Disease) 03/2013 - 01/2009
2	Acute Coronary Syndrome 04/2023 - 01/2022
2	Hyperglycemia 04/2023 - 01/2018
2	AIDS-Related Complex (ARC) 01/2023 - 10/2010
2	Bites and Stings (Sting) 01/2023 - 01/2023
2	Reperfusion Injury 12/2022 - 08/2012
2	Insulin Resistance 01/2022 - 01/2022
2	Brain Edema (Cerebral Edema) 01/2022 - 03/2013
2	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2015

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 07/2023 - 04/2012
16	Proteins (Proteins, Gene)FDA Link 05/2023 - 04/2010
11	Messenger RNA (mRNA)IBA 05/2023 - 10/2010
7	CytokinesIBA 02/2024 - 05/2016
7	EnzymesIBA 01/2022 - 03/2006
7	mangiferinIBA 08/2021 - 01/2012
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2002
6	RNA (Ribonucleic Acid)IBA 10/2023 - 05/2013
5	Interleukin-6 (Interleukin 6)IBA 01/2023 - 04/2012
5	Streptozocin (Streptozotocin)FDA Link 11/2022 - 01/2012
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2022 - 11/2015
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2014
5	Hepatitis B e AntigensIBA 01/2017 - 06/2004
4	Circular RNAIBA 07/2023 - 01/2018
4	InterferonsIBA 01/2023 - 11/2014
4	InflammasomesIBA 01/2022 - 01/2014
4	CollagenIBA 01/2021 - 09/2014
4	ParaffinIBA 10/2020 - 04/2010
4	Capecitabine (Xeloda)FDA Link 06/2018 - 06/2014
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2018 - 06/2014
3	HydrogelsIBA 02/2024 - 06/2019
3	Indicators and Reagents (Reagents)IBA 12/2023 - 01/2020
3	LigandsIBA 01/2023 - 11/2011
3	ChemokinesIBA 01/2023 - 08/2021
3	Long Noncoding RNAIBA 11/2022 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 11/2018
3	Phosphotransferases (Kinase)IBA 01/2022 - 08/2009
3	Methotrexate (Mexate)FDA LinkGeneric 12/2021 - 04/2002
3	Hemoglobins (Hemoglobin)IBA 05/2021 - 05/2007
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2019
3	Trastuzumab (Herceptin)FDA Link 11/2019 - 08/2012
3	XELOXIBA 06/2018 - 06/2014
3	Antiviral Agents (Antivirals)IBA 11/2014 - 01/2009
3	p38 Mitogen-Activated Protein KinasesIBA 09/2014 - 01/2012
2	Oxygen (Dioxygen)IBA 12/2023 - 01/2023
2	Amino Acids FDA Link 11/2023 - 01/2021
2	Sucrose (Saccharose)IBA 11/2023 - 01/2021
2	Glycoproteins (Glycoprotein)IBA 01/2023 - 11/2008
2	Competitive Endogenous RNAIBA 01/2023 - 01/2018
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023 - 01/2023
2	B7-H1 AntigenIBA 01/2023 - 09/2022
2	Cisplatin (Platino)FDA LinkGeneric 11/2022 - 01/2020
2	Carcinoembryonic AntigenIBA 04/2022 - 06/2018
2	NLR ProteinsIBA 01/2022 - 12/2016
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 07/2005
2	LipidsIBA 01/2022 - 12/2016

Therapy/Procedure

34	Therapeutics 04/2024 - 01/2009
7	Drug Therapy (Chemotherapy) 09/2022 - 01/2012
7	Kidney Transplantation 01/2017 - 08/2008
5	Neoadjuvant Therapy 04/2022 - 04/2009
4	Adjuvant Chemotherapy 04/2022 - 02/2013
3	Percutaneous Coronary Intervention 04/2023 - 01/2022
3	Transcranial Direct Current Stimulation 01/2022 - 01/2020
2	Immunotherapy 01/2023 - 07/2018
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2022 - 01/2022
2	Intraperitoneal Injections 11/2022 - 10/2017